TYCHE INDUSTRIES LTD. Share Price

BSE: 532384

S Cap

₹ 104.60

+0.00 (0.00%)

Last updated 14 Aug, 2026, 15:27 IST

TYCHE INDUSTRIES LTD. Share Price Today

As of 17 Aug 2026, TYCHE INDUSTRIES LTD. share price is ₹104.60. The stock opened at ₹107.00, compared to its previous close of ₹104.60. During today's trading session, TYCHE INDUSTRIES LTD. share price moved in the range of ₹103.00 to ₹107.00, with an average price of ₹105.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹99.00 and a high of ₹148.00.

₹103.00

0.00% up today

₹107.00

1D LOW

1D HIGH

Stock Performance

UnderperformingUnderperforming Nifty by 21.16 % in last 1 year

TYCHE INDUSTRIES LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,87,222-₹1,12,778 (-22.56%)

3 Year

₹3,07,139-₹1,92,861 (-38.57%)

5 Year

₹2,77,689-₹2,22,311 (-44.46%)

₹83.65₹125.45

Circuit Low

Circuit High

₹99.00₹148.00

52-Week Low

52-Week High

Circuit

₹83.65

₹125.45

52-week

₹99.00

₹148.00

About TYCHE INDUSTRIES LTD.

ISIN

INE443B01012

Sector Market Cap

₹ 107.16 Cr

Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

TYCHE INDUSTRIES LTD. Financial Highlights

Revenue: TYCHE INDUSTRIES LTD. reported revenue of ₹62.85 crore in FY26 vs ₹72.89 crore in FY25. It showed a decrease of 13.77% on a yearly basis.
Operating Profit: TYCHE INDUSTRIES LTD. reported an operating profit of ₹9.46 crore in FY26 vs ₹16.71 crore in FY25. It showed a decrease of 43.39% on a year-on-year basis.
Net Profit: TYCHE INDUSTRIES LTD. reported a net profit of ₹6.94 crore in FY26 vs ₹12.41 crore in FY25. It showed a decrease of 44.08% on a yearly basis.

TYCHE INDUSTRIES LTD. Quarterly Result Highlights

TYCHE INDUSTRIES LTD. reported revenue of ₹11.36 crore in Jun 2026, compared with ₹19.16 crore in Mar 2026, representing a decrease of 40.71% on a quarter-on-quarter (QoQ) basis.
TYCHE INDUSTRIES LTD. reported an operating loss of ₹0.05 crore in Jun 2026, compared with ₹1.70 crore in Mar 2026, representing a decrease of 102.94% on a quarter-on-quarter (QoQ) basis.
TYCHE INDUSTRIES LTD. reported a loss of ₹0.04 crore in Jun 2026, compared with ₹1.15 crore in Mar 2026, reflecting a decrease of 103.48% on a QoQ basis.
The earnings per share (EPS) of TYCHE INDUSTRIES LTD. stood at ₹12.20 during Jun 2026.

Know more

Promoters

61.97%

FII

0.00%

Other DII

0.00%

Retail and other

38.03%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

107.16

P/E

24.03

P/B

0.76

ROE

4.94%

D/E

0.00

ROCE

6.74%

Div. Yield

3.35%

EPS(TTM)

6.70

Turnover

0.34

EV/EBITDA

3.83

Net Margin

0.00%

Op. Margin

0.00%

ROA

3.01%

Quick Ratio

0.00

Curr. Ratio

16.46

Mkt Cap Cr

107.16

P/E

24.03

P/B

0.76

ROE

4.94%

D/E

0.00

ROCE

6.74%

Div. Yield

3.35%

EPS(TTM)

6.70

Turnover

0.34

EV/EBITDA

3.83

Net Margin

0.00%

Op. Margin

0.00%

ROA

3.01%

Quick Ratio

0.00

Curr. Ratio

16.46

Based on fundamentals, this stock's

Performance

Very Poor

Tyche Industries has not beaten FD return of 7%

Valuation

Overvalued

Tyche Industries appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,61,848.00	38.12	5.53	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,25,648.00	77.15	13.46	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,84,109.00	85.40	21.89	25.49%	1.69	13.85%	222.76	0.70%	0.49	58.70
Cipla	1,17,139.00	34.91	3.40	11.27%	0.00	14.95%	423.36	0.90%	0.45	43.52
Zydus Lifesciences	1,13,715.00	24.76	4.19	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Lupin	1,02,191.00	18.41	4.55	23.76%	0.04	24.88%	659.05	0.81%	0.57	129.18
Dr. Reddy's Laboratories	1,00,328.00	31.52	2.64	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Mankind Pharma	99,945.00	48.34	6.13	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Laurus Labs	98,064.00	89.94	18.50	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,296.90	25.95	2.54	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

TYCHE INDUSTRIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹65.47	₹69.51	₹75.39	₹62.27
Other Income	₹7.42	₹5.92	₹4.83	₹4.16
Total Revenue	₹72.89	₹75.43	₹80.21	₹66.42
Total Expenses	₹56.17	₹58.80	₹61.01	₹53.09
Profit Before Tax	₹16.71	₹16.63	₹19.08	₹12.64
Tax	₹4.31	₹4.39	₹4.91	₹3.31
Profit After Tax	₹12.41	₹12.24	₹14.17	₹9.33
EPS - Basic	₹12.20	₹11.78	₹13.74	₹9.18
EPS - Diluted	₹12.20	₹11.78	₹13.74	₹9.18

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹16.82	₹16.39	₹18.95	₹12.73
Income before WC changes	₹8.36	₹8.84	₹12.03	₹7.95
Change in Assets	-₹5.50	₹18.32	-₹13.00	₹1.52
Change in Liabilities	₹5.69	-₹19.45	₹7.41	-₹5.01
Change in WC	₹0.18	-₹1.13	-₹5.60	-₹3.49
Cash flow from Operations	₹8.54	₹7.71	₹6.43	₹4.46
Cash flow from Investing	-₹0.62	₹3.94	-₹3.12	₹3.16
Cash flow from Financing	-₹2.56	-₹2.05	-₹1.54	-₹1.02
Total Cash Flow	₹5.37	₹9.61	₹1.77	₹6.59
Cash (Start of the year)	₹78.89	₹69.28	₹67.51	₹60.92
Cash (End of the year)	₹84.26	₹78.89	₹69.28	₹67.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹26.47	₹21.63	₹24.27	₹19.24
Current Assets	₹120.94	₹113.05	₹112.44	₹101.03
Total Assets	₹147.41	₹134.68	₹136.72	₹120.27
Current Liabilities	₹9.62	₹6.68	₹16.57	₹12.83
Net Current Asset	₹111.32	₹106.37	₹95.87	₹88.20
Non-Current Liabilities	₹1.08	₹1.27	₹3.39	₹3.22
Equity Capital	₹136.70	₹126.74	₹116.75	₹104.22
Total Equity & Liabilities	₹147.41	₹134.68	₹136.72	₹120.27